Cargando…

Dopamine D3 Receptor Antagonists as Potential Therapeutics for the Treatment of Neurological Diseases

D3 receptors represent a major focus of current drug design and development of therapeutics for dopamine-related pathological states. Their close homology with the D2 receptor subtype makes the development of D3 selective antagonists a challenging task. In this review, we explore the relevance and t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maramai, Samuele, Gemma, Sandra, Brogi, Simone, Campiani, Giuseppe, Butini, Stefania, Stark, Holger, Brindisi, Margherita
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2016
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5050208/ https://www.ncbi.nlm.nih.gov/pubmed/27761108 http://dx.doi.org/10.3389/fnins.2016.00451

Ejemplares similares

Computational Tool for Fast in silico Evaluation of hERG K(+) Channel Affinity
por: Chemi, Giulia, et al.
Publicado: (2017)

In silico study of subtilisin-like protease 1 (SUB1) from different Plasmodium species in complex with peptidyl-difluorostatones and characterization of potent pan-SUB1 inhibitors
por: Brogi, Simone, et al.
Publicado: (2016)

Identification of Novel 3-Hydroxy-pyran-4-One Derivatives as Potent HIV-1 Integrase Inhibitors Using in silico Structure-Based Combinatorial Library Design Approach
por: Sirous, Hajar, et al.
Publicado: (2019)

Multiple Targeting Approaches on Histamine H(3) Receptor Antagonists
por: Khanfar, Mohammad A., et al.
Publicado: (2016)

A Repurposing Approach for Uncovering the Anti-Tubercular Activity of FDA-Approved Drugs with Potential Multi-Targeting Profiles
por: Battah, Basem, et al.
Publicado: (2019)

Covalent Reversible Inhibitors of Cysteine Proteases Containing the Nitrile Warhead: Recent Advancement in the Field of Viral and Parasitic Diseases
por: Brogi, Simone, et al.
Publicado: (2022)

Structure-based discovery of the first non-covalent inhibitors of Leishmania major tryparedoxin peroxidase by high throughput docking
por: Brindisi, Margherita, et al.
Publicado: (2015)

The green chemistry of chalcones: Valuable sources of privileged core structures for drug discovery
por: Marotta, Ludovica, et al.
Publicado: (2022)

A Therapeutic Perspective of HDAC8 in Different Diseases: An Overview of Selective Inhibitors
por: Fontana, Anna, et al.
Publicado: (2022)

Development of Quinazolinone Derivatives as Modulators of Virulence Factors of Pseudomonas aeruginosa Cystic Fibrosis Strains
por: Carullo, Gabriele, et al.
Publicado: (2023)

Crystal structures of Schistosoma mansoni histone deacetylase 8 reveal a novel binding site for allosteric inhibitors
por: Saccoccia, Fulvio, et al.
Publicado: (2022)

Perioperative utility of amisulpride and dopamine receptor antagonist antiemetics-a narrative review
por: Elias, Murad, et al.
Publicado: (2023)

Design and Synthesis of Oligopeptidic Parvulin Inhibitors
por: Relitti, Nicola, et al.
Publicado: (2022)

Orexin receptor antagonists as therapeutic agents for insomnia
por: Equihua, Ana C., et al.
Publicado: (2013)

Polypharmacological Approaches for CNS Diseases: Focus on Endocannabinoid Degradation Inhibition
por: Papa, Alessandro, et al.
Publicado: (2022)

Dopamine Receptors: Is It Possible to Become a Therapeutic Target for Depression?
por: Zhao, Fangyi, et al.
Publicado: (2022)

Dopamine receptor antagonists as potential therapeutic agents for ADPKD
por: Paul, Parama, et al.
Publicado: (2019)

Dopamine Homeostasis Imbalance and Dopamine Receptors-Mediated AC/cAMP/PKA Pathway Activation are Involved in Aconitine-Induced Neurological Impairment in Zebrafish and SH-SY5Y Cells
por: Zhou, Jie, et al.
Publicado: (2022)

Dopamine D(2) Antagonist-Induced Striatal Nur77 Expression Requires Activation of mGlu5 Receptors by Cortical Afferents
por: Maheux, Jérôme, et al.
Publicado: (2012)

Orexin 1 receptor antagonists in compulsive behavior and anxiety: possible therapeutic use
por: Merlo Pich, Emilio, et al.
Publicado: (2014)

Sphingosine-1-Phosphate Receptor-2 Antagonists: Therapeutic Potential and Potential Risks
por: Blankenbach, Kira V., et al.
Publicado: (2016)

Voltage-Dependent Dopamine Potency at D(1)-Like Dopamine Receptors
por: Ågren, Richard, et al.
Publicado: (2020)

Corrigendum: Dopamine homeostasis imbalance and dopamine receptors-mediated AC/cAMP/PKA pathway activation are involved in aconitine-induced neurological impairment in zebrafish and SH-SY5Y cells
por: Zhou, Jie, et al.
Publicado: (2023)

Beyond the dopamine receptor: novel therapeutic targets for treating schizophrenia
por: Coyle, Joseph T., et al.
Publicado: (2010)

Author Correction: The FAAH inhibitor URB597 suppresses hippocampal maximal dentate afterdischarges and restores seizure-induced impairment of short and long-term synaptic plasticity
por: Colangeli, Roberto, et al.
Publicado: (2018)

The FAAH inhibitor URB597 suppresses hippocampal maximal dentate afterdischarges and restores seizure-induced impairment of short and long-term synaptic plasticity
por: Colangeli, Roberto, et al.
Publicado: (2017)

Author Correction: The FAAH inhibitor URB597 suppresses hippocampal maximal dentate afterdischarges and restores seizure-induced impairment of short and long-term synaptic plasticity
por: Colangeli, Roberto, et al.
Publicado: (2018)

Caffeine and Selective Adenosine Receptor Antagonists as New Therapeutic Tools for the Motivational Symptoms of Depression
por: López-Cruz, Laura, et al.
Publicado: (2018)

Multitarget Therapeutic Strategies for Alzheimer's Disease: Review on Emerging Target Combinations
por: Maramai, Samuele, et al.
Publicado: (2020)

Dopamine-induced arrestin recruitment and desensitization of the dopamine D4 receptor is regulated by G protein-coupled receptor kinase-2
por: Burström, Viktor, et al.
Publicado: (2023)

Computer-Driven Development of an in Silico Tool for Finding Selective Histone Deacetylase 1 Inhibitors
por: Sirous, Hajar, et al.
Publicado: (2020)

Serotonin and dopamine receptors in motivational and cognitive disturbances of schizophrenia
por: Sumiyoshi, Tomiki, et al.
Publicado: (2014)

The Dopamine D5 Receptor Is Involved in Working Memory
por: Carr, Gregory V., et al.
Publicado: (2017)

Opportunities and perspectives for developing orexin receptor antagonists
por: Steiner, Michel A., et al.
Publicado: (2014)

Mineralocorticoid Receptor Antagonists in Diabetic Kidney Disease
por: Kawanami, Daiji, et al.
Publicado: (2021)

Agonist and antagonist effects of tobacco-related nitrosamines on human α4β2 nicotinic acetylcholine receptors
por: Brusco, Simone, et al.
Publicado: (2015)

The therapeutic potential of triptolide and celastrol in neurological diseases
por: Cui, Yueran, et al.
Publicado: (2022)

Total Synthesis of the Natural Chalcone Lophirone E, Synthetic Studies toward Benzofuran and Indole-Based Analogues, and Investigation of Anti-Leishmanial Activity
por: Pozzetti, Luca, et al.
Publicado: (2022)

Inhibition of A(2A) Adenosine Receptor Signaling in Cancer Cells Proliferation by the Novel Antagonist TP455
por: Gessi, Stefania, et al.
Publicado: (2017)

The therapeutic potential of ultra-short-acting β-receptor antagonists in perioperative analgesic: Evidence from preclinical and clinical studies
por: Fu, Linbin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cp1rf28p2thou7dbok61nqq20o